164 related articles for article (PubMed ID: 29951984)
1. Impact of change in serum albumin level during and after chemoradiotherapy in patients with locally advanced esophageal cancer.
Takeda K; Umezawa R; Takahashi N; Matsushita H; Kozumi M; Ishikawa Y; Yamamoto T; Takeda K; Jingu K
Esophagus; 2018 Jul; 15(3):190-197. PubMed ID: 29951984
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer.
Kimura J; Kunisaki C; Makino H; Oshima T; Ota M; Oba M; Takagawa R; Kosaka T; Ono HA; Akiyama H; Endo I
Dis Esophagus; 2016 Nov; 29(8):1071-1080. PubMed ID: 26471766
[TBL] [Abstract][Full Text] [Related]
3. The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Hsiao CC; Huang CC; Shih LH; Chen SW; Li SH
BMC Cancer; 2018 Aug; 18(1):837. PubMed ID: 30126380
[TBL] [Abstract][Full Text] [Related]
4. Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303).
Okuno T; Wakabayashi M; Kato K; Shinoda M; Katayama H; Igaki H; Tsubosa Y; Kojima T; Okabe H; Kimura Y; Kawano T; Kosugi S; Toh Y; Kato H; Nakamura K; Fukuda H; Ishikura S; Ando N; Kitagawa Y;
Int J Clin Oncol; 2017 Dec; 22(6):1042-1049. PubMed ID: 28717855
[TBL] [Abstract][Full Text] [Related]
5. Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer.
Zenda S; Hironaka S; Boku N; Yamazaki K; Yasui H; Fukutomi A; Yoshino T; Onozawa Y; Nishimura T
Dis Esophagus; 2008; 21(3):195-200. PubMed ID: 18430098
[TBL] [Abstract][Full Text] [Related]
6. Hematologic Markers as Prognostic Factors in Nonmetastatic Esophageal Cancer Patients under Concurrent Chemoradiotherapy.
Wu YF; Chu SC; Chang BS; Cheng YT; Wang TF
Biomed Res Int; 2019; 2019():1263050. PubMed ID: 30834254
[TBL] [Abstract][Full Text] [Related]
7. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer.
Di Fiore F; Lecleire S; Pop D; Rigal O; Hamidou H; Paillot B; Ducrotté P; Lerebours E; Michel P
Am J Gastroenterol; 2007 Nov; 102(11):2557-63. PubMed ID: 17680847
[TBL] [Abstract][Full Text] [Related]
8. Treatment-associated severe thrombocytopenia affects survival rate in esophageal cancer patients undergoing concurrent chemoradiotherapy.
Huang YM; Wang CH; Huang JS; Tsai CS; Yeh KY; Lan YJ; Wu TH; Chang PH; Chang YS; Lai CH
Indian J Cancer; 2015; 52(3):454-60. PubMed ID: 26905168
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
10. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients.
Zhang F; Chen Z; Wang P; Hu X; Gao Y; He J
Tumour Biol; 2016 Jul; 37(7):9323-31. PubMed ID: 26779631
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of radiotherapy plus erlotinib versus chemoradiotherapy for elderly patients with esophageal cancer: a propensity score-matched analysis.
Song T; Du D; Zhang X; Fang M; Wu S
Dis Esophagus; 2017 Sep; 30(9):1-10. PubMed ID: 28859362
[TBL] [Abstract][Full Text] [Related]
12. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
13. Low preoperative albumin-globulin score predicts favorable survival in esophageal squamous cell carcinoma.
Zhang F; Sun P; Wang ZQ; Wang de S; Wang Y; Zhang DS; Wang FH; Fu JH; Xu RH; Li YH
Oncotarget; 2016 May; 7(21):30550-60. PubMed ID: 27105522
[TBL] [Abstract][Full Text] [Related]
14. High-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages II-III esophageal cancer.
Suh YG; Lee IJ; Koom WS; Cha J; Lee JY; Kim SK; Lee CG
Jpn J Clin Oncol; 2014 Jun; 44(6):534-40. PubMed ID: 24771865
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer.
Otowa Y; Nakamura T; Yamamoto M; Kanaji S; Matsuda Y; Matsuda T; Oshikiri T; Sumi Y; Suzuki S; Kakeji Y
Dis Esophagus; 2017 Dec; 30(12):1-5. PubMed ID: 28881893
[TBL] [Abstract][Full Text] [Related]
16. Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy.
Zhou XL; Zhu WG; Zhu ZJ; Wang WW; Deng X; Tao WJ; Ji FZ; Tong YS
Oncologist; 2019 Aug; 24(8):e677-e686. PubMed ID: 31040254
[TBL] [Abstract][Full Text] [Related]
17. Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation.
Schernberg A; Moureau-Zabotto L; Rivin Del Campo E; Escande A; Ducreux M; Nguyen F; Goere D; Chargari C; Deutsch E
Oncotarget; 2017 Feb; 8(7):11579-11588. PubMed ID: 28086222
[TBL] [Abstract][Full Text] [Related]
18. Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer.
Clavier JB; Antoni D; Atlani D; Ben Abdelghani M; Schumacher C; Dufour P; Kurtz JE; Noel G
Dis Esophagus; 2014 Aug; 27(6):560-7. PubMed ID: 23106980
[TBL] [Abstract][Full Text] [Related]
19. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of neutrophil-to-lymphocyte ratio in patients treated with concurrent chemoradiotherapy for locally advanced oesophageal cancer.
Yoo EJ; Park JC; Kim EH; Park CH; Shim CN; Lee HJ; Chung HS; Lee H; Shin SK; Lee SK; Lee CG; Lee YC
Dig Liver Dis; 2014 Sep; 46(9):846-53. PubMed ID: 24970014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]